Innovation in Otolaryngology: Head and Neck Surgery

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Surgery".

Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 3864

Special Issue Editor


E-Mail Website
Guest Editor
Otorhinolaryngology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Interests: otorhinolaryngology; larynx; thyroid; parathyroid; sinonasal; ear; salivary glands; cancer

Special Issue Information

Dear Colleagues, 

The only real mechanism for both decreasing the cost and improving quality in medicine is through innovation and the creation of new technologies. In the field of otorhinolaryngology, these are related to voice and swallowing issues, hearing loss, ear diseases, head and neck cancer-related HPV, skull base surgery, transoral robotic surgery, salivary endoscopy, allergic rhinitis or sleep disorders. Working collaboratively with colleagues from pediatrics, neurology and neurosurgery, pulmonology, medical oncology, radiotherapy, ophthalmology and plastic surgery, among others, otorhinolaryngologists provide their patients with the most comprehensive care available. Further integration of eHealth in the field of otorhinolaryngology will follow the typical characteristics of a disruptive innovation to improve quality and safety, as well as efficacy and efficiency of care and patient engagement.

Dr. Magdalena Chirila
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • otorhinolaryngology
  • voice
  • swallowing issues
  • hearing loss
  • head and neck cancer-related HPV
  • skull base surgery
  • transoral robotic surgery
  • salivary endoscopy
  • allergic rhinitis
  • sleep disorders
  • eHealth

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

9 pages, 728 KiB  
Article
Plasma-Rich Fibrin—Regenerative Material in Tympanic Membrane Surgery
by Cristina Tiple, Magdalena Chirila, Stefan Cristian Vesa and Mirela Cristina Stamate
Medicina 2023, 59(7), 1292; https://doi.org/10.3390/medicina59071292 - 13 Jul 2023
Viewed by 1168
Abstract
Background and Objectives: Platelet-rich fibrin (PRF) membrane plays an important role in cell proliferation and aids in healing. This study aimed to assess the safety and efficacy of the addition of PRF to the graft in tympanoplasty. Materials and Methods: A [...] Read more.
Background and Objectives: Platelet-rich fibrin (PRF) membrane plays an important role in cell proliferation and aids in healing. This study aimed to assess the safety and efficacy of the addition of PRF to the graft in tympanoplasty. Materials and Methods: A retrospective study was conducted involving 47 patients with chronic dry eardrum perforation, who were candidates for different types of tympanoplasty (type I-IV). The study took place in the ENT department, County Emergency Clinical Hospital of Cluj-Napoca. In group 1 (27 patients) tympanoplasty was performed with a cartilage graft, while in group 2 (20 patients) a cartilage graft was used with the addition of a PRF membrane. The PRF clot was extracted and transformed into a thin membrane. Postoperative evaluation included otoendoscopy and otomicroscopy at 1, 3, 6, and 12 months after surgery, as well as pure-tone audiometry at 12 months. Results: Postoperative follow-up at 1, 3, 6, and 12 months showed a higher rate of graft survival in the PRF group than in the non-PRF group. At the 12-month mark, a successful outcome was observed in 95.0% of patients in the PRF group, while the success rate in group 1 was 70.4% (p < 0.05). The postoperative hearing threshold value was statistically significantly lower in the group with PRF, compared to the non-PRF group, being 18.4 ± 10.4 dB and 27.6 ± 16.2 dB (p < 0.001), respectively. Although the postoperative air-bone gap value did not differ significantly between groups, there was a greater improvement in the PRF group (p < 0.7). The PRF was well tolerated, and the incisions healed perfectly. Conclusions: The PRF membrane increases the rate of autograft survival and is therefore an effective material for patients with chronic perforations of the tympanic membrane. Full article
(This article belongs to the Special Issue Innovation in Otolaryngology: Head and Neck Surgery)
Show Figures

Figure 1

9 pages, 584 KiB  
Article
Endoscopic Sphenopalatine Artery Cauterization in the Management of Recurrent Posterior Epistaxis
by Sever Septimiu Pop, Cristina Tiple, Mirela Cristina Stamate and Magdalena Chirila
Medicina 2023, 59(6), 1128; https://doi.org/10.3390/medicina59061128 - 12 Jun 2023
Cited by 1 | Viewed by 2147
Abstract
Background and Objectives: Endoscopic sphenopalatine artery cauterization (ESPAC) has become a reliable and effective surgical procedure for managing posterior epistaxis. The objectives of our study were to evaluate the effectiveness of ESPAC in the management of posterior epistaxis and the possible factors [...] Read more.
Background and Objectives: Endoscopic sphenopalatine artery cauterization (ESPAC) has become a reliable and effective surgical procedure for managing posterior epistaxis. The objectives of our study were to evaluate the effectiveness of ESPAC in the management of posterior epistaxis and the possible factors that lead to the failure of the procedure. Materials and Methods: We performed a retrospective analysis of all patients who underwent ESPAC between 2018 and 2022. We retrospectively reviewed the demographic data, patients’ co-morbidities, medical treatment conditions, whether other surgical procedures were performed in addition to the ESPAC, and the success rate of ESPAC. Results: 28 patients were included in our study. After ESPAC, epistaxis was successfully managed in 25 patients (89.28%). Of all patients undergoing ESPAC, three (10.7%) presented re-bleeding. In two patients, we performed an endoscopic revision surgery with re-cauterization of the sphenopalatine foramen area, together with anterior and posterior ethmoidectomy, followed by fat occlusion/obliteration of these sinuses. In one patient, fat obliteration of the anterior and posterior ethmoid was also unsuccessful, and we performed an external carotid artery ligation at the level of the neck with no recurrence afterwards. Conclusions: Endoscopic cauterization of the sphenopalatine artery remains a safe, effective, and reliable surgical procedure in the management of recurrent posterior epistaxis. The use of anticoagulant drugs and the association of hypertension and other heart and liver diseases do not materialize as factors influencing surgical failure. Full article
(This article belongs to the Special Issue Innovation in Otolaryngology: Head and Neck Surgery)
Show Figures

Figure 1

Back to TopTop